
| Serial Number | 87059929 |
| Word Mark | MEKTOVI (BINIMETINIB) |
| Filing Date | Friday, June 3, 2016 |
| Status | 710 - CANCELLED - SECTION 8 |
| Status Date | Friday, July 26, 2024 |
| Registration Number | 5381495 |
| Registration Date | Tuesday, January 16, 2018 |
| Mark Drawing | 3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
| Published for Opposition Date | Tuesday, April 4, 2017 |
| Description of Mark | The mark consists of the words "MEKTOVI" and below "MEKTOVI" in smaller lettering is the word "(binimetinib)". The upper right of "MEKTOVI" is a series of overlapping circles arranged in a horizontal manner. |
| Goods and Services | Anti-infectives; Anti-inflammatories; Antibacterial pharmaceuticals; Antibiotics; Antifungal preparations; Antivirals; Cardiovascular pharmaceuticals; Dermatological pharmaceutical products; Inhaled pharmaceutical preparations for the treatment of respiratory diseases and disorders; Pharmaceutical preparations acting on the central nervous system; Pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; Pharmaceutical preparations for the treatment and prevention of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; Pharmaceutical preparations for the treatment of eye diseases and conditions; Pharmaceutical preparations for the treatment of heart rhythm disorders; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Pharmaceutical preparations for the treatment of kidney diseases; Pharmaceutical preparations for treating diabetes; Pharmaceutical preparations for treating hypertension; Pharmaceutical preparations for treating skin disorders; Pharmaceutical preparations for use in dermatology; Pharmaceutical preparations for use in urology; Pharmaceutical products for ophthalmological use; Pharmaceutical products for the prevention and treatment of cancer and tumors; Pharmaceutical products for the treatment of bone diseases; Pharmaceutical products for treating respiratory diseases; Pharmaceutical products for treating respiratory diseases and asthma; all of the foregoing incorporating the inhibitor binimetinib |
| Indication of Colors claimed | Color is not claimed as a feature of the mark. |
| NOT AVAILABLE | "BINIMETINIB" |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 006, 018, 044, 046, 051, 052 |
| Class Status Code | 2 - Sec. 8 - Entire Registration |
| Class Status Date | Friday, July 26, 2024 |
| Primary Code | 005 |
| First Use Anywhere Date | Thursday, September 21, 2017 |
| First Use In Commerce Date | Thursday, September 21, 2017 |
| Party Name | Array Biopharma Inc. |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 03 - Corporation |
| Address | Boulder, CO 80301 |
| Party Name | Array Biopharma Inc. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | Boulder, CO 80301 |
| Party Name | Array Biopharma Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Boulder, CO 80301 |
| Event Date | Event Description |
| Friday, June 10, 2016 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Tuesday, June 7, 2016 | NEW APPLICATION ENTERED |
| Saturday, June 11, 2016 | NOTICE OF DESIGN SEARCH CODE E-MAILED |
| Thursday, September 15, 2016 | ASSIGNED TO EXAMINER |
| Friday, September 16, 2016 | NON-FINAL ACTION WRITTEN |
| Friday, September 16, 2016 | NON-FINAL ACTION E-MAILED |
| Friday, September 16, 2016 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Thursday, October 13, 2016 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Thursday, October 13, 2016 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Friday, October 14, 2016 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Friday, October 14, 2016 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Friday, October 28, 2016 | ASSIGNED TO LIE |
| Friday, November 4, 2016 | LAW OFFICE PUBLICATION REVIEW COMPLETED |
| Monday, November 14, 2016 | WITHDRAWN FROM PUB - MANAGING ATTORNEY REQUEST |
| Wednesday, February 15, 2017 | PREVIOUS ALLOWANCE COUNT WITHDRAWN |
| Wednesday, February 22, 2017 | EXAMINERS AMENDMENT -WRITTEN |
| Wednesday, February 22, 2017 | EXAMINERS AMENDMENT E-MAILED |
| Wednesday, February 22, 2017 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Wednesday, February 22, 2017 | EXAMINER'S AMENDMENT ENTERED |
| Wednesday, February 22, 2017 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Tuesday, February 28, 2017 | LAW OFFICE PUBLICATION REVIEW COMPLETED |
| Wednesday, March 15, 2017 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, April 4, 2017 | PUBLISHED FOR OPPOSITION |
| Tuesday, April 4, 2017 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, May 30, 2017 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Thursday, November 30, 2017 | TEAS STATEMENT OF USE RECEIVED |
| Thursday, November 30, 2017 | SOU TEAS EXTENSION RECEIVED |
| Thursday, November 30, 2017 | SOU EXTENSION 1 FILED |
| Thursday, November 30, 2017 | USE AMENDMENT FILED |
| Wednesday, December 6, 2017 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| Wednesday, December 6, 2017 | SOU EXTENSION 1 GRANTED |
| Wednesday, December 6, 2017 | STATEMENT OF USE PROCESSING COMPLETE |
| Wednesday, December 6, 2017 | SU-EXAMINER'S AMENDMENT WRITTEN |
| Wednesday, December 6, 2017 | EXAMINERS AMENDMENT E-MAILED |
| Wednesday, December 6, 2017 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Wednesday, December 6, 2017 | EXAMINER'S AMENDMENT ENTERED |
| Thursday, December 7, 2017 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Friday, December 8, 2017 | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED |
| Saturday, December 9, 2017 | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED |
| Tuesday, January 16, 2018 | REGISTERED-PRINCIPAL REGISTER |
| Thursday, June 4, 2020 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
| Thursday, June 4, 2020 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Thursday, June 4, 2020 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Thursday, June 4, 2020 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Thursday, June 4, 2020 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
| Monday, January 16, 2023 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED |
| Friday, July 26, 2024 | CANCELLED SEC. 8 (6-YR) |